Biogen Inc Stock Price on April 22, 2021

BIIB Stock  USD 200.41  7.23  3.74%   
Below is the normalized historical share price chart for Biogen Inc extending back to September 17, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Biogen stands at 200.41, as last reported on the 24th of April, with the highest price reaching 200.41 and the lowest price hitting 192.75 during the day.
IPO Date
16th of September 1991
200 Day MA
244.4427
50 Day MA
214.285
Beta
(0.01)
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Biogen Stock, it is important to understand the factors that can impact its price. Biogen Inc secures Sharpe Ratio (or Efficiency) of -0.23, which signifies that the company had a -0.23% return per unit of risk over the last 3 months. Biogen Inc exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biogen's Mean Deviation of 1.11, risk adjusted performance of (0.14), and Standard Deviation of 1.58 to double-check the risk estimate we provide.
  
At present, Biogen's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 283 M, whereas Other Stockholder Equity is projected to grow to (2.5 B). . At present, Biogen's Price To Operating Cash Flows Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price To Free Cash Flows Ratio is expected to grow to 31.81, whereas Price To Sales Ratio is forecasted to decline to 3.62. Biogen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2329

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBIIB

Estimated Market Risk

 1.6
  actual daily
14
86% of assets are more volatile

Expected Return

 -0.37
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.23
  actual daily
0
Most of other assets perform better
Based on monthly moving average Biogen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biogen by adding Biogen to a well-diversified portfolio.
Price Book
1.9465
Enterprise Value Ebitda
17.2165
Price Sales
2.9289
Shares Float
144.8 M
Wall Street Target Price
297.8

Biogen Valuation on April 22, 2021

It is possible to determine the worth of Biogen on a given historical date. On April 22, 2021 Biogen was worth 213.12 at the beginning of the trading date compared to the closed value of 210.62. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Biogen stock. Still, in general, we apply an absolute valuation method to find Biogen's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biogen where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Biogen's related companies.
 Open High Low Close Volume
04/11/2022
  213.12    216.00    210.55    210.62    868,994  
  211.01    212.91    206.62    208.06    976,141  
Backtest Biogen  |  Biogen History  |  Biogen Valuation Next  
Open Value
213.12
208.33
Downside
210.62
Closing Value
217.91
Upside

Biogen Trading Date Momentum on April 22, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

Biogen Inc Fundamentals Correlations and Trends

By evaluating Biogen's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Biogen's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Biogen financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Biogen Stock history

Biogen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biogen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biogen Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biogen stock prices may prove useful in developing a viable investing in Biogen
Last ReportedProjected for Next Year
Common Stock Shares Outstanding145.6 M283 M
Net Income Applicable To Common Shares3.5 BB

Biogen Quarterly Net Working Capital

3.42 Billion

Biogen Stock Technical Analysis

Biogen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Biogen technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biogen trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Biogen Period Price Range

Low
April 11, 2022
-2.5  -1.17%
High

 213.12 

     

 210.62 

Biogen April 24, 2024 Market Strength

Market strength indicators help investors to evaluate how Biogen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biogen shares will generate the highest return on investment. By undertsting and applying Biogen stock market strength indicators, traders can identify Biogen Inc entry and exit signals to maximize returns

Biogen Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Biogen's price direction in advance. Along with the technical and fundamental analysis of Biogen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biogen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Transaction History
View history of all your transactions and understand their impact on performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stocks Directory
Find actively traded stocks across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.55)
Earnings Share
7.98
Revenue Per Share
67.972
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0458
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.